As shown in Fig. 2, pretreatment with 2 mM cAMP could not diminish VEGF-enhanced tumor cell adhesion although it completely abolished VEGF-enhanced microvessel permeability (Fig. 1). The gene discussed is VEGFA; the disease is neoplasm.